Search Results - "CLAPERON, Audrey"
-
1
Epithelial-mesenchymal transition in cholangiocarcinoma: From clinical evidence to regulatory networks
Published in Journal of hepatology (01-02-2017)“…Summary Cholangiocarcinoma (CCA) is an aggressive tumor with a poor prognosis due to its late clinical presentation and the lack of effective non-surgical…”
Get full text
Journal Article -
2
The IGF2/IR/IGF1R Pathway in Tumor Cells and Myofibroblasts Mediates Resistance to EGFR Inhibition in Cholangiocarcinoma
Published in Clinical cancer research (01-09-2018)“…Cholangiocarcinoma (CCA) is a desmoplastic tumor of the biliary tree in which epidermal growth factor receptor (EGFR) is overexpressed and contributes to…”
Get full text
Journal Article -
3
EGF/EGFR axis contributes to the progression of cholangiocarcinoma through the induction of an epithelial-mesenchymal transition
Published in Journal of hepatology (01-08-2014)“…Background & Aims Epithelial-mesenchymal transition (EMT) is a cellular process involved in cancer progression. The first step of EMT consists in the…”
Get full text
Journal Article -
4
Mitogenic Insulin Receptor-A Is Overexpressed in Human Hepatocellular Carcinoma due to EGFR-Mediated Dysregulation of RNA Splicing Factors
Published in Cancer research (Chicago, Ill.) (01-07-2013)“…Insulin receptor (IR) exists as two isoforms resulting from the alternative splicing of IR pre-mRNA. IR-B promotes the metabolic effects of insulin, whereas…”
Get full text
Journal Article -
5
Combining BH3-mimetics to target both BCL-2 and MCL1 has potent activity in pre-clinical models of acute myeloid leukemia
Published in Leukemia (01-04-2019)“…Improving outcomes in acute myeloid leukemia (AML) remains a major clinical challenge. Overexpression of pro-survival BCL-2 family members rendering…”
Get full text
Journal Article -
6
Hepatic myofibroblasts promote the progression of human cholangiocarcinoma through activation of epidermal growth factor receptor
Published in Hepatology (Baltimore, Md.) (01-12-2013)“…Intrahepatic cholangiocarcinoma (CCA) is characterized by an abundant desmoplastic environment. Poor prognosis of CCA has been associated with the presence of…”
Get full text
Journal Article -
7
Loss of ezrin in human intrahepatic cholangiocarcinoma is associated with ectopic expression of E-cadherin
Published in Histopathology (01-08-2016)“…Aims Ezrin connects proteins from the plasma membrane to the subcortical cytoskeleton, and contributes to epithelial integrity by interacting with the…”
Get full text
Journal Article -
8
Mitogen-activated protein kinase-activated protein kinase 2 mediates resistance to hydrogen peroxide-induced oxidative stress in human hepatobiliary cancer cells
Published in Free radical biology & medicine (01-12-2015)“…The development and progression of liver cancer are characterized by increased levels of reactive oxygen species (ROS). ROS-induced oxidative stress impairs…”
Get full text
Journal Article -
9
Roles of the scaffolding proteins NHERF in liver biology
Published in Clinics and research in hepatology and gastroenterology (01-03-2011)“…Summary Scaffold proteins are defined by the presence of specific protein-binding domains (e.g. PDZ domains) that assemble several proteins into functional…”
Get full text
Journal Article -
10
Ezrin-Radixin-Moesin-Binding Phosphoprotein (EBP50), an Estrogen-Inducible Scaffold Protein, Contributes to Biliary Epithelial Cell Proliferation
Published in The American journal of pathology (01-03-2009)“…Ezrin-radixin-moesin-binding phosphoprotein 50 (EBP50) anchors and regulates apical membrane proteins in epithelia. EBP50 is inducible by estrogen and may…”
Get full text
Journal Article -
11
Immunohistochemical profile of ezrin and radixin in human liver epithelia during fetal development and pediatric cholestatic diseases
Published in Clinics and research in hepatology and gastroenterology (01-04-2013)“…Summary Aim Ezrin and radixin are actin-binding proteins that contribute to the integrity of epithelia. Abnormalities of bile secretion occur primarily in…”
Get full text
Journal Article -
12
The Kell and XK proteins of the Kell blood group are not co-expressed in the central nervous system
Published in Brain research (25-05-2007)“…Abstract The Kell blood group is constituted by two covalently linked antigens at the surface of red blood cells, Kell and Kx. Whereas Kell is a…”
Get full text
Journal Article -
13
The Kell protein of the common K2 phenotype is a catalytically active metalloprotease, whereas the rare Kell K1 antigen is inactive. Identification of novel substrates for the Kell protein
Published in The Journal of biological chemistry (03-06-2005)“…The Kell blood group is a highly polymorphic system containing over 20 different antigens borne by the protein Kell, a 93-kDa type II glycoprotein that…”
Get full text
Journal Article -
14
Mechanical induction of the tumorigenic β-catenin pathway by tumour growth pressure
Published in Nature (London) (02-07-2015)“…Magnetically induced mechanical strain mimicking the pressure exerted by a growing tumour in the mouse colon is shown to activate the tumorigenic β-catenin…”
Get full text
Journal Article -
15
Mechanical induction of the tumorigenic b-catenin pathway by tumour growth pressure
Published in Nature (London) (01-07-2015)“…The tumour microenvironment may contribute to tumorigenesis owing to mechanical forces such as fibrotic stiffness or mechanical pressure caused by the…”
Get full text
Journal Article -
16
Discovery of S64315, a Potent and Selective Mcl‑1 Inhibitor
Published in Journal of medicinal chemistry (25-11-2020)“…Myeloid cell leukemia 1 (Mcl-1) has emerged as an attractive target for cancer therapy. It is an antiapoptotic member of the Bcl-2 family of proteins, whose…”
Get full text
Journal Article -
17
Structure-Guided Discovery of a Selective Mcl‑1 Inhibitor with Cellular Activity
Published in Journal of medicinal chemistry (08-08-2019)“…Myeloid cell leukemia 1 (Mcl-1), an antiapoptotic member of the Bcl-2 family of proteins, whose upregulation when observed in human cancers is associated with…”
Get full text
Journal Article -
18
S55746 is a novel orally active BCL-2 selective and potent inhibitor that impairs hematological tumor growth
Published in Oncotarget (13-04-2018)“…Escape from apoptosis is one of the major hallmarks of cancer cells. The B-cell Lymphoma 2 (BCL-2) gene family encodes pro-apoptotic and anti-apoptotic…”
Get full text
Journal Article -
19
Abstract 257: Targeting AML through apoptosis activation using Bcl-2/Mcl-1 or Bcl-2/Hdm2 inhibitor combination therapies
Published in Cancer research (Chicago, Ill.) (01-07-2019)“…Abstract Acute myeloid leukemia (AML) is an aggressive and heterogeneous hematologic malignancy, characterized by uncontrolled proliferation and impaired…”
Get full text
Journal Article -
20
Abstract 1276: Identification of S65487/VOB560 as a potent and selective intravenous 2nd-generation BCL-2 inhibitor active in wild-type and clinical mutants resistant to Venetoclax
Published in Cancer research (Chicago, Ill.) (01-07-2021)“…Abstract The B-cell Lymphoma 2 (BCL-2) gene family encodes pro-apoptotic and anti-apoptotic proteins that are key regulators of the apoptotic process…”
Get full text
Journal Article